BTIG Reiterates Buy Rating on Medline Inc (MDLN)

March 9, 2026 5:20 AM

BTIG analyst David Larsen reiterated a Buy rating and $55.00 price target on Medline Inc (NASDAQ: MDLN).The analyst comments "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found